Since CXCR4 appears to have an important role in the pathogenesis and progression of pancreatic cancer [1], [2], [3], our work has important clinical implications in the identification of a novel therapeutic use for these established anti-malarial agents. Here, CXCR4 is linked to familial pancreatic carcinoma.